Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)-Reference-Cited by-同舟云学术

Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)

Published:2022-10-02 Issue:3 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Tsujimoto Shin‐Ichi¹²^ORCID,Sakamoto Kenichi¹³,Nakano Yoshiko⁴^ORCID,Mizuno Takanori¹⁵,Shindo Takahiro⁶,Watanabe Junichi⁷,Sato‐Otsubo Aiko⁵^ORCID,Osumi Tomoo¹^ORCID,Matsumoto Kimikazu¹^ORCID,Tomizawa Daisuke¹^ORCID,Kato Motohiro¹⁴⁵^ORCID

Affiliation:

1. Children's Cancer Center National Center for Child Health and Development Tokyo Japan

2. Department of Pediatrics Graduate School of Medicine Yokohama City University Yokohama Japan

3. Department of Pediatrics Shiga University of Medical Science Otsu Japan

4. Department of Pediatrics The University of Tokyo Hospital Tokyo Japan

5. Department of Pediatrics Graduate School of Medicine The University of Tokyo Tokyo Japan

6. Division of Cardiology National Center for Child Health and Development Tokyo Japan

7. Department of Hematology Saitama Medical Center Saitama Medical University Saitama Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30033

Reference13 articles.

1. Mitochondrial dysfunction, AMPK activation and peroxisomal metabolism: A coherent scenario for non-canonical 3-methylglutaconic acidurias

2. The 3-methylglutaconic acidurias: what’s new?

3. Complete resolution of epileptic spasms with vigabatrin in a patient with 3‐methylglutaconic aciduria caused by TIMM50 gene mutation

4. Barth syndrome

5. Neutropenia in Barth syndrome